bacteri
colon
viral
respiratori
pathogen
play
import
role
exacerb
chronic
obstruct
pulmonari
diseas
copd
especi
patient
requir
viral
andor
bacteri
infect
detect
patient
copd
although
bacteria
consid
major
caus
copd
exacerb
antibiot
commonli
use
treat
import
viral
infect
copd
exacerb
mention
introduct
wide
use
viral
cultur
realtim
polymeras
chain
reaction
pcr
link
viral
infect
copd
emphas
recent
studi
copd
patient
airway
inflamm
virusassoci
seemung
et
al
found
viral
infect
caus
frequent
copd
exacerb
prolong
viral
infect
secondari
bacteri
infect
frequent
detect
copd
biomark
commonli
use
differenti
infect
noninfect
caus
copd
exacerb
previou
studi
suggest
patient
treat
antibiot
accord
procalcitonin
pct
level
exacerb
copd
reduc
antibiot
howev
pct
differenti
bacteri
viral
caus
copd
exacerb
requir
admiss
intens
care
unit
whether
serum
inflammatori
marker
creactiv
protein
crp
pct
distinguish
bacteri
viral
infect
patient
copd
exacerb
requir
emerg
depart
ed
visit
remain
controversi
studi
conduct
clarifi
peripher
blood
white
blood
cell
wbc
count
pct
crp
level
relationship
viral
bacteri
pathogen
copd
patient
requir
ed
visit
exacerb
copd
patient
age
greater
year
old
visit
ed
linkou
changgung
memori
hospit
due
copd
exacerb
april
august
prospect
enrol
studi
copd
diagnos
base
global
initi
chronic
obstruct
lung
diseas
gold
guidelin
exacerb
defin
worsen
patient
respiratori
symptom
beyond
normal
daytoday
variat
patient
current
smoker
exsmok
smoke
histori
greater
packyear
postbronchodil
spirometri
prior
ed
visit
demonstr
ratio
forc
expiratori
volum
first
second
forc
vital
capac
fvc
document
patient
histori
bronchial
asthma
abnorm
chest
radiograph
indic
respiratori
diseas
exclud
patient
hospit
cardiovascular
diseas
acut
pulmonari
edema
acut
pulmonari
embol
pneumothorax
activ
pneumonia
also
exclud
activ
pneumonia
diagnos
chest
radiograph
obtain
ed
medic
record
review
analyz
follow
data
age
sex
bodi
mass
index
bmi
medic
use
prior
ed
admiss
clinic
symptom
worsen
dyspnea
increas
sputum
volum
purul
fever
cough
sore
throat
wheez
famili
cluster
common
cold
symptom
peripher
blood
wbc
count
serum
crp
pct
level
spirometri
hospit
day
current
exacerb
prior
corticosteroid
use
defin
corticosteroid
prescrib
mg
prednisolon
per
day
day
within
year
ed
visit
anthonisen
criteria
defin
presenc
one
three
symptom
includ
increas
dyspnea
increas
sputum
volum
increas
sputum
number
exacerb
follow
year
retrospect
collect
sputum
obtain
spontan
product
specimen
sent
central
laboratori
linkou
changgung
memori
hospit
bacteri
cultur
posit
bacteri
cultur
defin
moder
heavi
growth
bacteria
semiquantit
cultur
oropharyng
swab
specimen
collect
patient
viru
identif
use
viru
isol
multiplex
rtpcr
mrtpcr
assay
oropharyng
swab
specimen
inocul
onto
mdck
cell
isol
virus
cell
cultur
incub
week
final
identif
virus
perform
use
immunofluoresc
assay
ifa
screen
kit
chemicon
inc
temecula
ca
usa
respiratori
virus
mrtpcr
assay
design
amplifi
conserv
region
viral
target
mrtpcr
perform
use
ml
thinwal
pcr
tube
biorad
icycl
abi
rtpcr
mixtur
use
assay
iii
onestep
rtpcr
kit
invitrogen
life
technolog
corp
carlsbad
ca
usa
reaction
contain
follow
kit
reagent
probe
primer
abi
master
mixtur
contain
mmoll
deoxyribonucleotid
triphosph
dntp
mmoll
specimen
dna
rna
extract
control
final
reaction
volum
adjust
pcrgrade
water
rtpcr
amplif
perform
use
follow
condit
initi
complementari
dna
step
minut
follow
minut
cycl
second
second
second
statist
analys
perform
use
spss
spss
window
spss
inc
chicago
il
usa
statist
packag
prism
graphpad
softwar
inc
la
jolla
ca
usa
valu
report
mean
standard
deviat
sd
differ
among
subgroup
compar
use
test
fisher
exact
test
expect
number
event
less
signific
level
statist
test
set
p
consid
statist
signific
studi
conduct
accord
amend
declar
helsinki
studi
approv
institut
review
board
chang
gung
memori
hospit
written
inform
consent
obtain
patient
copd
patient
exacerb
requir
ed
visit
includ
studi
period
none
patient
includ
twice
patient
receiv
longterm
oxygen
therapi
studi
mean
l
predict
valu
baselin
characterist
copd
patient
includ
age
sex
bmi
predict
fvc
predict
gold
stage
packyear
tobacco
use
previou
inhal
oral
medic
peripher
blood
wbc
count
serum
crp
pct
level
shown
tabl
total
patient
present
two
anthonisen
criteria
patient
recurr
exacerb
requir
ed
visit
subsequ
period
total
patient
admit
ward
patient
discharg
ed
four
hospit
patient
admit
intens
care
unit
acut
respiratori
failur
three
need
mechan
ventil
support
last
receiv
noninvas
ventil
support
none
patient
die
virus
detect
oropharynx
patient
tabl
parainfluenza
viru
type
commonli
detect
viru
follow
influenza
inf
human
rhinoviru
adenoviru
identifi
one
patient
influenza
b
respiratori
syncyti
viru
rsv
found
one
patient
simultan
detect
adenoviru
patient
without
confirm
presenc
virus
divid
two
group
patient
virusposit
patient
virusneg
signific
betweengroup
differ
age
bmi
fvc
length
hospit
day
number
exacerb
subsequ
year
figur
show
laboratori
data
time
ed
admiss
copd
exacerb
patient
wbc
count
crp
pct
level
significantli
differ
virusposit
virusneg
group
larger
proport
virusposit
patient
previous
treat
oral
corticosteroid
virusneg
patient
versu
viralposit
group
present
sore
throat
symptom
viralneg
group
versu
famili
cluster
common
cold
symptom
significantli
higher
viralposit
group
viralneg
group
versu
patient
copd
exacerb
posit
sputum
bacteri
cultur
tabl
haemophilu
influenza
commonli
identifi
bacteri
strain
follow
haemophilu
parainfluenza
sputum
bacteri
cultur
one
patient
grew
staphylococcu
aureu
acinetobact
baumannii
chlamydia
speci
found
mrtpcr
two
case
patient
posit
mycoplasma
pcr
statist
signific
differ
bacteriaposit
bacterianeg
patient
age
bmi
fvc
clinic
symptom
medic
use
prior
ed
admiss
length
hospit
day
recurr
exacerb
subsequ
year
wbc
crp
pct
level
significantli
differ
bacteriaposit
bacterianeg
group
figur
among
seven
patient
pct
ngml
three
sputum
posit
bacteria
growth
none
subject
posit
virus
signific
differ
bacteriaposit
group
lower
ratio
bacterianeg
group
versu
viru
bacteria
identifi
five
patient
one
inf
streptococcu
pneumonia
anoth
adenoviru
h
influenza
third
adenoviru
h
influenza
fourth
h
parainfluenza
last
escherichia
coli
human
metapneumoviru
tabl
show
result
univari
multivari
analysi
variabl
associ
recurr
exacerb
subsequ
period
result
indic
increas
sputum
volum
copd
exacerb
requir
ed
visit
independ
associ
higher
risk
recurr
exacerb
subsequ
year
percentag
patient
free
readmiss
ed
year
analyz
curv
evalu
logrank
test
significantli
differ
bacteriaposit
bacterianeg
group
curv
patient
virusposit
virusneg
also
differ
significantli
figur
outcom
analyz
specif
pct
crp
level
percentag
patient
free
readmiss
ed
also
show
statist
signific
differ
figur
studi
demonstr
virus
identifi
oropharynx
bacteri
infect
confirm
patient
copd
exacerb
requir
ed
visit
commonli
identifi
viru
commonli
found
bacterium
h
influenza
higher
percentag
virusposit
patient
present
sore
throat
famili
cluster
common
cold
symptom
analysi
mainten
medic
prescrib
ed
visit
show
percentag
patient
oral
corticosteroid
treatment
prior
ed
admiss
higher
virusposit
group
multivari
analysi
evalu
risk
factor
recurr
exacerb
show
higher
rate
recurr
copd
exacerb
period
origin
ed
visit
increas
sputum
volum
first
copd
exacerb
howev
commonli
use
biomark
infect
serum
crp
pct
level
aid
differenti
bacteri
viral
infect
patient
copd
exacerb
rapid
declin
lung
function
observ
copd
patient
patient
exacerb
also
higher
mortal
rate
frequent
exacerb
requir
hospit
papi
et
al
found
infect
exacerb
detect
patient
bacteria
identifi
virus
copd
exacerb
pathogen
identifi
associ
longer
hospit
stay
noninfect
howev
posit
rate
viral
identif
patient
copd
exacerb
requir
hospit
vari
differ
public
studi
kherad
et
al
sampl
viru
identif
obtain
via
nasopharyng
swab
identif
perform
use
qualit
rtpcr
assay
overal
virusposit
rate
mcmanu
et
al
show
patient
hospit
copd
exacerb
sputum
sampl
posit
studi
patient
copd
exacerb
requir
mechan
ventil
virus
identifi
nasopharyng
aspir
posterior
pharyng
studi
viral
pathogen
detect
oropharyng
swab
patient
virusposit
rate
oropharyng
swab
thu
lower
previou
studi
possibl
caus
variat
may
includ
season
geograph
differ
etiolog
virusassoci
copd
exacerb
recent
systemat
review
rate
detect
virus
associ
copd
exacerb
highest
anoth
possibl
caus
differ
result
site
sampl
collect
studi
collect
oropharyng
swab
nasopharyng
swab
sputum
sampl
might
result
differ
rate
viral
detect
studi
commonli
identifi
virus
patient
copd
exacerb
requir
ed
visit
inf
viru
human
rhinoviru
result
similar
find
cameron
et
al
studi
australia
frequent
detect
viral
etiolog
inf
recent
review
eight
studi
picornaviru
common
viru
western
countri
influenza
viru
common
h
influenza
common
bacteri
pathogen
copd
exacerb
previou
pseudomona
aeruginosa
klebsiella
pneumonia
also
emphas
recent
studi
h
influenza
h
parainfluenza
k
pneumonia
commonli
identifi
bacteria
data
provid
worthwhil
epidemiolog
result
viral
bacteri
etiolog
copd
exacerb
may
import
implic
appropri
empir
select
antibiot
proper
manag
copd
exacerb
biomark
commonli
use
differenti
infect
noninfect
caus
copd
exacerb
compar
wbc
crp
pct
level
bacteriaposit
bacterianeg
patient
biomark
show
statist
signific
betweengroup
differ
studi
similarli
wbc
crp
pct
level
differ
virusposit
virusneg
patient
statist
signific
pct
biomark
specif
bacteri
infect
might
use
guid
decis
regard
antibiot
treatment
howev
could
distinguish
bacteri
viral
noninfecti
caus
copd
daniel
et
al
compar
crp
pct
marker
clinic
outcom
copd
exacerb
found
pct
good
biomark
copd
exacerb
patient
low
pct
valu
benefit
sever
bacteri
infect
airway
patient
copd
exacerb
probabl
insuffici
induc
signific
pct
product
sputum
purul
suggest
use
determin
initi
antibiot
treatment
hospit
patient
copd
howev
differ
sputum
purul
bacteriaposit
bacterianeg
group
studi
retrospect
cohort
studi
patient
hospit
copd
exacerb
treat
although
gold
guidelin
suggest
use
antibiot
exacerb
remain
controversi
consid
antibiot
sign
bacteri
infect
studi
rothberg
et
al
support
antibiot
administr
improv
outcom
among
patient
hospit
copd
copd
exacerb
patient
oropharyng
virus
identifi
like
previou
corticosteroid
treatment
sore
throat
famili
cluster
common
cold
symptom
clinician
consid
virusinduc
copd
exacerb
patient
present
sore
throat
famili
cluster
common
cold
symptom
total
patient
recurr
exacerb
subsequ
period
exacerb
hurst
et
al
report
cohort
patient
copd
show
patient
stage
stage
stage
copd
exacerb
preced
bafadhel
et
al
divid
copd
exacerb
four
distinct
cluster
includ
bacteri
viral
eosinophil
predomin
pauciinflammatori
biomark
sputum
serum
analyz
clinic
variabl
associ
recurr
exacerb
rate
increas
sputum
volum
initi
copd
exacerb
independ
risk
factor
recurr
exacerb
subsequ
period
studi
provid
addit
inform
investig
copd
phenotyp
recurr
exacerb
limit
studi
mention
first
techniqu
use
studi
distinguish
acut
infect
colon
therefor
select
patient
requir
ed
visit
rather
symptombas
exacerb
second
although
studi
conduct
tertiari
teach
hospit
still
singlecent
multicent
studi
result
obtain
low
number
patient
third
whether
patient
prior
influenza
pneumococc
vaccin
record
could
clarifi
influenc
vaccin
copd
exacerb
studi
viru
assess
cultur
pcr
bacteria
identifi
cultur
final
viru
identif
obtain
oropharyng
swab
specimen
obtain
specimen
nasopharyng
swab
lower
respiratori
tract
viru
identif
actual
rate
viru
identif
differ
sampl
site
unknown
conclus
virus
bacteria
play
import
role
copd
exacerb
wbc
pct
crp
level
good
indic
bacteri
infect
copd
exacerb
increas
sputum
volum
copd
exacerb
higher
rate
recurr
exacerb
subsequ
period
understand
etiolog
bacteria
virus
copd
exacerb
might
aid
appropri
manag
copd
exacerb
